ARCHIVES

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

IARC Publishes Fourth Edition of European Code Against Cancer

October 17, 2014

Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA

May 9, 1997

Congress Passes Unprecedented 15% Increase For NIH On Last Day Of Session

October 23, 1998

NCI relaxes Core Grants Support For Clinical Trials Research

December 11, 1992

DCT Board Ok’s PA, BRM Contract Concepts

October 30, 1992

Cancer Survivorship: NCI Offers Training Program, video, For Health Professionals

October 24, 1997